Clinical trials · St. Louis, MO
Malignant Female Reproductive System Neoplasm clinical trials in St. Louis
We’re tracking 5 recruiting malignant female reproductive system neoplasm studies with a site in or near St. Louis — including Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near St. Louis
- NCT05564377RecruitingPhase 2
Find targeted cancer treatments using genetic testing
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
St Louis, MissouriAges Any age - NCT06513962RecruitingPhase 3
Triptorelin to protect ovaries in young women with cancer
This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.
St Louis, MissouriAges Up to 39 years - NCT07215624Recruiting
Survey on blood clot prevention after cancer surgery
This study surveys surgeons and surgical advanced practice providers about how they prevent blood clots (deep vein thrombosis) in patients after cancer surgery. It aims to understand current practices and improve future care.
St Louis, MissouriAges 18 years+ - NCT04851119RecruitingPhase 1/Phase 2
Tegavivint for kids and young adults with hard-to-treat solid tumors
This early-phase study tests tegavivint to see how well it works and how safe it is for children and young adults with solid cancers that have come back or are not responding. It may be an option if your tumor type (including certain lymphomas or desmoid tumors) matches the study’s rules.
St Louis, MissouriAges 1–30 - NCT06126276RecruitingPhase 2
Testing neratinib with or without palbociclib for HER2+ solid tumors
This trial tests two targeted drugs—neratinib alone or with palbociclib—for people with HER2-positive solid tumors (other than breast cancer) that have returned or not gone away. The goal is to see if blocking HER2 and CDK4/6 can shrink or slow the tumor.
O'Fallon, IllinoisAges 18 years+
Hear when a new Malignant Female Reproductive System Neoplasm trial opens near St. Louis, MO
We’ll email you when one opens near St. Louis, MO — at most once a week, no account needed, unsubscribe anytime.
Malignant Female Reproductive System Neoplasm trials in other cities
Where these studies are running near St. Louis
Institutions with a site for the recruiting malignant female reproductive system neoplasm studies listed above.
- Mercy Hospital Saint Louis · 3 studies
- Washington University in St. Louis · 3 studies
- Cancer Care Center of O'Fallon · 2 studies
- Memorial Hospital East · 2 studies
- Siteman Cancer Center · 2 studies
- Siteman Cancer Center at Saint Peters Hospital · 2 studies
- Siteman Cancer Center at West County Hospital · 2 studies
- Mercy Hospital Washington
What taking part in a malignant female reproductive system neoplasm study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting malignant female reproductive system neoplasm studies in Missouri.
Common questions
- Are there malignant female reproductive system neoplasm clinical trials near St. Louis?
- Yes. We're currently tracking 5 recruiting malignant female reproductive system neoplasm studies with a site near St. Louis, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a malignant female reproductive system neoplasm study near St. Louis?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in St. Louis to take part?
- Not necessarily. These studies have a site near St. Louis, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a malignant female reproductive system neoplasm trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New malignant female reproductive system neoplasm studies open near St. Louis regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.